November 2025, From the Field
The summer and fall brought more clarity on President Donald Trump’s trade and fiscal policies. Now investors must weigh the implications for inflation, the economy, and monetary policy.
Trade frameworks with key partners suggest that the effective tariff rate for the U.S. is likely to end up somewhere between 10% and 20%—compared with roughly 2.5% at the start of 2025.
Nevertheless, U.S. economic activity has also held up reasonably well, with real‑time barometers of growth decreasing only modestly. Here, the boom in spending on artificial intelligence (AI) has been a strong tailwind that has helped to offset prolonged sluggishness in manufacturing and housing.
Meanwhile, the tax and spending legislation that Congress passed in July should be modestly stimulative over the next few years. The question surrounds the extent to which more favorable tax treatment of capital expenditures and research and development will spur business investment.
The combination of higher tariffs, lower corporate taxes, and stricter immigration policies has helped to keep inflation expectations elevated in the U.S., contributing to concerns that higher prices could crimp corporate profit margins and consumer spending.
The labor market bears watching in this environment. Small businesses, which account for more than 70% of U.S. employment, could face pressure to lay off employees because they tend to have less pricing power and more sensitivity to the economy and interest rates.
The Federal Reserve must tread carefully as it walks the tightrope of seeking to keep inflation in check while being mindful of economic growth and the labor market. Policymakers must also contend with political pressure to lower rates. Cutting rates too much in a growing economy could add to inflationary pressures.
In this dynamic environment, a top‑down understanding of the interplay between government policy, the economy, and the outlook for different asset classes can be especially powerful when it’s combined with deep insights into industries and individual companies in the U.S. and beyond.
The following section highlights some of the key policy areas we’re watching and the possible implications for asset allocation.
What we're watching
Potential implications
What we're watching
Potential implications
What we're watching
Potential implications
What we're watching
Potential implications
What we're watching
Potential implications
What we're watching
Potential implications
1 Duration measures a bond’s sensitivity to changes in interest rates.
Risks
Fixed income securities are subject to credit risk, liquidity risk, call risk, and interest rate risk. As interest rates rise, bond prices generally fall. Small‑cap stocks have generally been more volatile in price than large‑cap stocks. Because of the cyclical nature of natural resource companies, their stock prices and rates of earnings growth may follow an irregular path. While U.S. government‑backed securities generally are considered to be among the highest credit quality, they are subject to market risk. The primary source of risk is the possibility of rising interest rates, which generally cause bond prices to fall. In periods of no or low inflation, other types of bonds, such as U.S. Treasury bonds, may perform better than Treasury inflation-protected securities. Financial services companies may be hurt when interest rates rise sharply and may be vulnerable to rapidly rising inflation. International investments can be riskier than U.S. investments due to the adverse effects of currency exchange rates; differences in market structure and liquidity; as well as specific country, regional, and economic developments. These risks are generally greater for investments in emerging markets. The value approach to investing carries the risk that the market will not recognize a security’s intrinsic value for a long time or that a stock judged to be undervalued may actually be appropriately priced. Health sciences firms are often dependent on government funding and regulation and are vulnerable to product liability lawsuits and competition from low‑cost generic products. Growth stocks are subject to the volatility inherent in common stock investing, and their share price may fluctuate more than that of a income-oriented stocks. All charts and tables are shown for illustrative purposes only.
Important Information
Outside of the United States, this is intended for investment professional use only. Not for further distribution.
This material is being furnished for informational and/or marketing purposes only and does not constitute an offer, recommendation, advice, or solicitation to sell or buy any security.
Prospective investors should seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services.
Past performance is not a guarantee or a reliable indicator of future results. All investments involve risk, including possible loss of principal.
Information presented has been obtained from sources believed to be reliable, however, we cannot guarantee the accuracy or completeness. The views contained herein are those of the author(s), are as of November 2025, are subject to change, and may differ from the views of other T. Rowe Price Group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.
All charts and tables are shown for illustrative purposes only. Actual future outcomes may differ materially from any estimates or forward‑looking statements provided.
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.
Australia—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. For Wholesale Clients only.
Canada—Issued in Canada by T. Rowe Price (Canada), Inc. T. Rowe Price (Canada), Inc.’s investment management services are only available to non‑individual Accredited Investors and non‑individual Permitted Clients as defined under National Instrument 45‑106 and National Instrument 31‑103, respectively. T. Rowe Price (Canada), Inc. enters into written delegation agreements with affiliates to provide investment management services.
EEA—Unless indicated otherwise this material is issued and approved by T. Rowe Price (Luxembourg) Management S.à r.l. 35 Boulevard du Prince Henri L‑1724 Luxembourg which is authorised and regulated by the Luxembourg Commission de Surveillance du Secteur Financier. For Professional Clients only.
New Zealand—Issued by T. Rowe Price Australia Limited (ABN: 13 620 668 895 and AFSL: 503741), Level 28, Governor Phillip Tower, 1 Farrer Place, Sydney NSW 2000, Australia. No Interests are offered to the public. Accordingly, the Interests may not, directly or indirectly, be offered, sold or delivered in New Zealand, nor may any offering document or advertisement in relation to any offer of the Interests be distributed in New Zealand, other than in circumstances where there is no contravention of the Financial Markets Conduct Act 2013.
Switzerland—Issued in Switzerland by T. Rowe Price (Switzerland) GmbH, Talstrasse 65, 6th Floor, 8001 Zurich, Switzerland. For Qualified Investors only.
UK—This material is issued and approved by T. Rowe Price International Ltd, Warwick Court, 5 Paternoster Square, London EC4M 7DX which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only.
USA—Issued in the USA by T. Rowe Price Investment Services, Inc., distributor and T. Rowe Price Associates, Inc., investment adviser, 1307 Point Street, Baltimore, MD 21231, which are regulated by the Financial Industry Regulatory Authority and the U.S. Securities and Exchange Commission, respectively.
© 2025 T. Rowe Price. All Rights Reserved. T. Rowe Price, INVEST WITH CONFIDENCE, the Bighorn Sheep design, and related indicators (see troweprice.com/ip) are trademarks of T. Rowe Price Group, Inc. All other trademarks are the property of their respective owners.